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Abstract The binding of glycosaminoglycans to a synthetic
peptide (SKAQKAQAKQAKQAQKAQKAQAKQAKQW^
CONH2), consisting of a hybrid consensus heparin binding
sequence, is studied using circular dichroism, fluorescence
anisotropy and nuclear magnetic resonance techniques. The
results unveil certain novel features, most importantly, the
peptide binds preferentially to iduronic acid containing glycos-
aminoglycans and the dissociation constant for the peptide^
heparin complex was found to be 30 nM. Interestingly, higher
order intermolecular association(s)/aggregation was not ob-
served, especially at saturating concentrations of the ligand.
The helical structure of the peptide backbone, induced upon
binding to a particular glycosaminoglycan is directly related to
their binding affinity. In our opinion, studies on such unconven-
tional hybrid peptide sequences containing low density basic
amino acid residues would lead to the design of sequence specific
glycosaminoglycan binding peptides. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Glycosaminoglycans have been demonstrated to mediate a
wide range of biological activities such as cell adhesion, cell
motility, cell proliferation and tissue morphogenesis by bind-
ing to various cell regulatory proteins such as the chemokines,
growth factors, enzymes, enzyme inhibitors, extracellular ma-
trix proteins, toxins and proteins from microbial agents [1^8].
It is well accepted that the electrostatic interaction between
the sulfates of the glycosaminoglycan chain and the basic
residues on the protein contribute signi¢cantly to this biomo-
lecular recognition process [2,8]. Studies have been carried out
using model peptides containing either lysine/arginine rich or
those abiding the consensus heparin binding amino acid se-
quence(s) (XBBXBX or XBBBXXBX). The results of these
studies, in conjunction with the statistical analysis of the hep-
arin binding amino acid sequences in proteins, indicate that
the spatial distance between the basic amino acid residues is
the major determinant involved in the binding process [8^13].
In spite of the growing importance of the protein^glycosami-
noglycan recognition process none of the studies [8,11,13,14],
until date, have addressed the di¡erential binding ability of
the designed peptides to various glycosaminoglycans. It is
possible that the high density of the positively charged resi-
dues on the designed peptides would, predictably, hinder the
selectivity in binding. Therefore optimization of the number
and position of the positively charged amino acid residues in
the designed peptides is essential to achieve substrate speci¢c-
ity. In this context, we embarked upon studying the interac-
tion of various glycosaminoglycans with a low density lysine
peptide (K8) using circular dichroism, £uorescence anisotropy
and nuclear magnetic resonance techniques. We demonstrate
that the designed peptide binds preferentially to iduronic acid
containing glycosaminoglycans with reasonably high a⁄nity.
2. Materials and methods
The de novo designed 28-residue low density lysine peptide (K8:
SKAQKAQAKQAKQAQKAQKAQAKQAKQW^CONH2) was syn-
thesized at SynPep Corp. (CA, USA) and was further puri¢ed using a
semipreparative C18 reverse phase HPLC column with appropriate
water^acetonitrile gradient containing 0.1% TFA. The authenticity
of the peptide was con¢rmed by amino acid analysis and mass spec-
trometry. Low molecular weight heparin (Hep), heparan sulfate (HS),
dermatan sulfate (DS), chondroitin sulfate A (CSA), chondroitin sul-
fate C (CSC) and hyaluronic acid (HA) were purchased from Sigma
(USA). Titrations of K8 with di¡erent GAGs were performed in 10
mM phosphate bu¡er (pH 7.4) at 25‡C, unless otherwise mentioned.
The titrations were carried out by adding aliquots of a particular
GAG to a constant concentration of K8. The concentration of the
peptide was determined from its extinction coe⁄cient of 1280 M31
cm31 at 280 nm [15]. The concentration of Hep was determined by the
uronic acid assay [16].
2.1. Fluorescence measurements
Anisotropy measurements were made using an SLM 4800 £uorim-
eter with an excitation and emission wavelength of 280 nm and 350
nm, respectively. The £uorescence intensity (I) and the gain (G) were
obtained in parallel and perpendicular modes. The £uorescence aniso-
tropy values were calculated using the relation R = (RV3RH)/
(RV+RH) where RH = GeIe/GPIP and RV = Ge/GP [17,18].
2.2. Circular dichroism spectroscopy
All CD measurements, in the far UV region (195 nm to 260 nm) of
the spectrum, were made using a 1 cm pathlength cell on an AVIV
CD spectropolarimeter equipped with a programmable heating unit.
The spectropolarimeter was calibrated using d10-camphor sulfonic
acid. The thermal stability of the peptide upon binding to various
glycosaminoglycans was inferred from the changes in the mean resi-
due ellipticity values at 222 nm. In order to evaluate the van’t Ho¡
enthalpy associated with the complex formation, the titration of the
peptide (K8) with heparin was performed at di¡erent temperatures
(288 K, 293 K, 298 K, 303 K and 308 K).
2.3. Data analysis
The apparent dissociation constant values were estimated from the
changes in the £uorescence anisotropy upon titrating K8 with a given
glycosaminoglycan, using the non-linear relation
F  Fo  F s3F o=2PtKd  nLt  Pt
Kd  nLt  Pt234nLtPt0:5
where Fo and Fs represent the anisotropy values of the peptide in the
absence and presence of saturating concentrations of the ligand (gly-
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cosaminoglycan); Pt and Lt are the total concentrations of the peptide
and the ligand, respectively; Kd is the apparent dissociation constant
of the peptide^oligosaccharide complex.
2.4. NMR spectroscopy
One-dimensional 1H-NMR of K8 (1 mM in 10 mM sodium phos-
phate bu¡er, pH 7.4), at di¡erent concentration of low molecular
weight heparin, was measured on a 500 MHz NMR spectrometer
using a spectral width of 6000 Hz. Each spectrum was an average
of 64 scans and was referenced to 3-(trimethylsilyl)propionate. 15N-
HSQC [19] experiments were performed on a 15N-Ala-K8 (all alanines
labeled with 15N) with a spectral width of 100 ppm (512 data points)
and 4 ppm (2048 data points) in F2 and F1 dimensions, respectively.
The spectra were processed using XWIN-NMR software.
3. Results and discussion
3.1. Peptide design
The heparin binding domains of a few proteins, notably
thrombospondin [20], antithrombin [21], vitronectin [22],
IGFBP-5 [23] and IGFBP-3 [24], contain the basic amino
acid residues arranged in an (i,i+3) order. This enables the
basic residues to orient in nearly the same direction, provided
the secondary structure is K-helix and are thus conducive for
binding to negatively charged ligands such as glycosaminogly-
cans. Studies on synthetic peptides derived from the heparin
binding domain(s) of these proteins indicate a change in the
backbone conformation of the peptide upon binding to hep-
arin. Complementarily, the oligosaccharide derived from hep-
arin has been shown to adopt a helix-like conformation
[25,26]. With these as a clue, we designed a peptide with ly-
sines at alternate positions of three and four. Such an arrange-
ment of the basic residues represents a hybrid of the heparin
binding consensus sequences proposed by Cardin and Wein-
traub (XBBXBX and XBBBXXBX). Helical wheel represen-
tation of the amino acid sequence (not shown) of K8 indicates
that the lysines are arranged on one side of the helical axis.
Therefore, it is envisaged that the peptide could adopt K-hel-
ical structure upon binding to glycosaminoglycans. Glutamine
and alanine were opted as the intervening residues as they
have high intrinsic propensity to adopt helical conformation,
under favorable conditions [27^30]. The inclusion of trypto-
phan served dual purpose, as a probe for the estimation of
peptide concentration and also for £uorescence anisotropy
measurements.
3.2. Titration with heparin
The binding strength of K8 was initially examined using
immobilized heparin (HiTrap, Pharmacia). It was observed
that 0.7 M of NaCl was required to elute K8 from the heparin
a⁄nity column. In general, proteins/peptides that could be
eluted with more than 1.0 M NaCl are considered to possess
high a⁄nity for heparin and those required less than 0.3 M
NaCl are predicted to exhibit weaker binding. This indicates
that the designed peptide, K8, binds quite signi¢cantly with
heparin. The peptide was also titrated with soluble heparin
and its binding was monitored by observing the changes in
the far UV region of the circular dichroic (CD) spectra and
also by the changes in the £uorescence anisotropy values. The
CD spectra (in the far UV region) exhibited absorption bands
at 195 nm and 214 nm implying that the intrinsic backbone
conformation of K8 was an extended charged coil (Fig. 1).
This appeared to be a characteristic feature of highly charged
peptides [31,32]. Upon heparin addition, double minima at
206 nm and 222 nm with concurrent appearance of a maxi-
mum at 195 nm seems to develop in the CD spectra of the
peptide (Fig. 1). This indicates that the designed peptide, K8,
does bind to soluble heparin and that the backbone adopts an
K-helical conformation upon binding [33]. Such conforma-
tional changes have been reported for several heparin binding
segments of proteins and also for synthetic peptides upon
binding to heparin [8,14,31]. In addition, we monitored the
binding of K8 with Hep from the changes in the £uorescence
anisotropy of the peptide. The dissociation constant, calcu-
lated from this isotherm (see Section 2), was found to be 30
nM (Fig. 2).
In order to authenticate the binding of K8 to Hep and also
to examine the possibility of the formation of higher order
molecular associates, the interaction of K8 with Hep was also
followed by monitoring the changes in the proton resonances
of the peptide during the titration. The amide proton reso-
nances of the peptide exhibited a gradual dispersion with si-
Fig. 1. Far UV region of the CD spectrum of 8K34 (5 WM) at dif-
ferent concentrations of Hep. Heparin concentration from top to
bottom (at 222 nm) is 0 WM, 1 WM, 2 WM, 4 WM and 10 WM.
Fig. 2. Changes in the anisotropy values of K8 upon titrating with
Hep. The best ¢t was obtained with Kd = 30 nm and n = 1 in the
non-linear equation described in Section 2.
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multaneous up¢eld shift. This clearly indicates that the pep-
tide backbone adopts an K-helical structure upon binding to
heparin [34,35]. As the amide protons are not well resolved in
the 1D spectra, we acquired the 15N-HSQC spectrum of the
peptide (15N-Ala-K8) in the absence and presence of saturat-
ing concentrations of heparin (Fig. 3). The dispersion of the
proton resonances is more pronounced in the 15N-HSQC
spectrum. Moreover, the line widths of these cross-peaks,
both in the absence and presence of heparin, did not exhibit
dramatic changes. These results clearly emphasize the absence
of higher order intermolecular associates, especially at satu-
rating concentrations of heparin.
3.3. Titration with other glycosaminoglycans
The peptide was titrated with various glycosaminoglycans
(HS, DS, CSA, CSC and HA). The CD spectrum of the pep-
tide does exhibit changes (formation of double minima at 206
nm and 222 nm) in the far UV region when the titrant was
either HS or DS (Fig. 4). Interestingly, no signi¢cant changes
in the CD signals were observed when the peptide was titrated
with CSA (Fig. 4). It should be mentioned that the marginal
changes in the ellipticity values of K8, observed upon titrating
with either CSC or HA are not associated with the formation
of helix. This small increase could be due to the presence of
higher molecular associates owing to the possible formation of
very weak/non-speci¢c peptide^CSC/HA complexes. There-
fore, the results obtained from the circular dichroism spectra
indicate that the peptide interacts with HS and DS (in addi-
tion to Hep) but not with CSA, CSC and HA. To authenti-
cate this result, £uorescence anisotropy measurements were
made upon titrating the peptide with glycosaminoglycans.
Changes in the anisotropy values for K8 were observed
upon titration with DS and HS but not with CSA (data not
shown). The changes in the anisotropy values associated with
the titration of K8 with either CSC or HA could be due to
non-speci¢cities in the interaction. Therefore the results of the
£uorescence anisotropy measurements corroborate well with
the data obtained from the circular dichroism measurements,
thus demonstrating that the peptide preferentially interacts
with HS and DS. Analysis of the molecular structure of these
di¡erent glycosaminoglycans reveals that Hep, HS and DS
contain iduronic acid as the hexuronic acid moiety whereas
the other glycosaminoglycans used in this study have the cor-
responding epimer, glucuronic acid. It has to be emphasized
that Hep and HS contain a mixture of glucuronic acid and
iduronic acid sugars. Lack of binding by HA could be attrib-
uted to the lack of sulfation of the hydroxyls, in addition to
the presence of glucuronic acid. Such a di¡erential binding
ability might also be due to higher conformational £exibility
Fig. 3. 15N-HSQC spectra of 15Ala-8K34 in the absence (A) and presence (B) of Hep. The transition from the unstructured to an ordered con-
formation for 8K34 upon binding to Hep is evident from the increase in the dispersion of the cross-peaks both in 1H and 15N dimensions.
Fig. 4. Changes in the mean residue ellipticity values of 8K34 (at
222 nm) upon titrating with di¡erent GAGs. The titrations were
performed in 10 mM phosphate bu¡er, pH 7.4.
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of the iduronic acids than compared to a seemingly rigid
conformation of glucuronic acids [36]. Thus, it could also be
envisaged that an induced ¢t mechanism used to explain the
peptide^glycosaminoglycan interaction requires not only the
changes in the peptide backbone conformation but also the
sugar chain. Therefore, the results of CD and £uorescence
anisotropy con¢ne to the view point that the designed peptide,
K8, interacts with those glycosaminoglycans that lodge the
iduronic acid sugar.
In order to assess the relative binding strengths of the pep-
tide with glycosaminoglycans, the thermal melting curves of
the peptide, in the presence of saturating concentrations of the
iduronic acid containing glycosaminoglycans, were analyzed.
The thermal melting curves did not exhibit a sigmoidal trace,
which is quite expected of peptides lacking rigid tertiary struc-
tures (Fig. 5). However, qualitative analysis indicates that the
stability of the complexes decreases in the order
HepsHSsDS (Fig. 5). The trend could also be correlated
to the inherent di¡erences in the sulfation pattern of these
glycosaminoglycans. As DS is the least sulfated among the
iduronic acid containing glycosaminoglycans used in the
present study, the binding appears to be relatively weaker.
It should also be stated that a clear correlation between the
percentage of the helix induced to the corresponding binding
strength is observed. Such trends have also been observed
with the heparin binding studies using Cardin^Weintraub se-
quences [31].
3.4. Comparison with other studies
The peptide used in the present study has been demon-
strated to preferentially bind to iduronic acid containing gly-
cosaminoglycans. This is in contrast to the fact that the ho-
mopolymers of lysine/arginine/ornithine could bind to all
glycosaminoglycans [32]. This could imply that the high con-
formational £exibility of the iduronic acid sugars cannot be
used exclusively for explaining the substrate speci¢city. The
disparity in the binding preferences observed by Gelman and
Blackwell and in the present study could be attributed to the
nature of the peptides used for the study. Irrespective of the
glycosaminoglycan used, the homopolymers adopted helical
conformation upon complex formation. In contrast, we ¢nd
that the helical conformation is induced in K8 only upon
interacting with the iduronic acid containing glycosaminogly-
cans. Therefore these studies indicate that helix induction ac-
companies the binding reaction. It should be noted that there
is no preferential distribution of the charges in the case of
homopolypeptides, owing to which the non-speci¢cities in
the interaction are higher. On the other hand, the structure
of K8 is more ordered with the positive charges distributed on
one side of the helix. Such an orientation of the charges would
de¢nitely minimize the non-speci¢cities in the interaction with
glycosaminoglycans. Moreover, the studies with polylysine
and polyarginine clearly indicate the presence of higher mo-
lecular associates or aggregates [32]. Formation of aggregates
(or higher molecular associates) is a major concern in the
study of peptide/protein glycosaminoglycan studies. This phe-
nomenon could arise due to mere charge neutralization, upon
binding, which would lead to poor solubility of the complex
or due to the occurrence of non-speci¢c interactions. It is
quite interesting to note that the results of the present study
vividly demonstrate the absence of higher molecular associ-
ates.
Heparin binding studies using the peptides, consisting of the
tandem repeats of Cardin^Weintraub motifs have been carried
out recently [31]. The results of this study imply that the
binding behavior of the peptide to heparin is largely depen-
dent on the peptide:heparin ratios. The authors observe that
the helical conformation of the peptide that is induced at
lower concentration of heparin, melts when the molar ratio
of the heparin/peptide is greater than one. On the contrary,
the present study on K8 indicates that the K8^heparin com-
plex is quite stable and the induced helical conformation per-
sists even in the presence of excess molar concentrations of
heparin. Such di¡erences in the binding behavior could be
attributed to either (a) the spacings between the positively
charged lysine residues or (b) the intervening amino acid res-
idues. Verrechio et al. [31], based on the studies using di¡erent
mutant peptides, claim that the intervening residues (except
the presence of proline/glycine) do not have prominent role in
the binding process. In the present study, we deduced the
change in the van’t Ho¡ enthalpy associated with the inter-
action of K8 with heparin. A value of 32.94 kcal/mol (vH)
associated with the formation of K8^heparin complex is com-
parable to those obtained in the heparin binding studies using
short peptides [11,14]. Such lower values for vH imply that
the electrostatic forces dominate in the interaction of K8 with
heparin and that the presence of either glutamine or alanine
does not contribute to the binding of K8 with heparin. There-
fore, it is obvious that the patterns and spacings of the lysine
residues in the peptides used in these studies ([31] and present
study) play a signi¢cant role in dictating the binding behavior.
Therefore, in our opinion, the density of the positively
charged residues, in addition to the interresidual spacings
could be a very crucial factor in the peptide^heparin recogni-
tion process.
In conclusion, the present study paves way for the design of
non-conventional heparin/glycosaminoglycan binding amino
acid sequences. These sequences which do not contain dense
clusters of basic residues (6 30% compared to s 50% in con-
ventional heparin binding sequences) might enable speci¢city
in the glycosaminoglycan recognition. Such speci¢cities are
duly important in the design of high a⁄nity peptides to a
given glycosaminoglycan sequence which could ultimately
¢nd application in modulating the biological processes in
the cell, mediated by glycosaminoglycans.
Fig. 5. Changes in the fraction of unfolded species of 8K34 upon
increasing the temperature. The fraction of unfolded species was cal-
culated based on the mean residue ellipticity values at 222 nm. The
denaturation was monitored under saturating concentrations of
Hep, HS and DS.
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